QSYMIA

This brand name is authorized in United States.

Active ingredients

The drug QSYMIA contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Phentermine UNII `0K2I505OTV` - PHENTERMINE HYDROCHLORIDE
	Read more about Phentermine
`2`	Topiramate UNII `0H73WJJ391` - TOPIRAMATE
	Topiramate is classified as a sulfamate-substituted monosaccharide. The precise mechanism by which topiramate exerts its antiseizure and migraine prophylaxis effects are unknown.
	Read more about Topiramate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
QSYMIA Extended release capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	62541-201, 62541-202, 62541-203, 62541-204

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.